Initial and innate responses to viral infections--pattern setting in immunity or disease.
about
Galectin-9 functionally impairs natural killer cells in humans and miceRe-evaluating the role of natural killer cells in innate resistance to herpes simplex virus type 1Emerging concepts in immunity to hepatitis C virus infection.Subversion of cytokine networks by virally encoded decoy receptorsDecoding the complexity of type I interferon to treat persistent viral infectionsAlpha/beta interferon protects adult mice from fatal Sindbis virus infection and is an important determinant of cell and tissue tropismStealth and cunning: hepatitis B and hepatitis C viruses.Regulation of PKR and IRF-1 during hepatitis C virus RNA replication.Natural killer cells in infection and inflammation of the lungSleep, immunity and shift workers: A reviewAlveolar epithelial cell chemokine expression triggered by antigen-specific cytolytic CD8(+) T cell recognition.Type II pneumocyte-CD8+ T-cell interactions. Relationship between target cell cytotoxicity and activation.Antibody and inflammatory response-mediated severity of pandemic 2009 (pH1N1) influenza virus.FimH adhesin of type 1 fimbriae is a potent inducer of innate antimicrobial responses which requires TLR4 and type 1 interferon signalling.NK and NKT cell-independent contribution of interleukin-15 to innate protection against mucosal viral infectionNK cells in HIV-1 infection: evidence for their role in the control of HIV-1 infection.The role of alpha/beta and gamma interferons in development of immunity to influenza A virus in miceModulation of immunity against herpes simplex virus infection via mucosal genetic transfer of plasmid DNA encoding chemokines.Persistent virus infection inhibits type I interferon production by plasmacytoid dendritic cells to facilitate opportunistic infections.Full genome comparison and characterization of avian H10 viruses with different pathogenicity in Mink (Mustela vison) reveals genetic and functional differences in the non-structural gene.Modulation of host innate and adaptive immune defenses by cytomegalovirus: timing is everythingAssociation of activating KIR copy number variation of NK cells with containment of SIV replication in rhesus monkeys.Suppression of proinflammatory cytokine expression by herpes simplex virus type 1.Increased natural killer cell cytotoxicity and NKp30 expression protects against hepatitis C virus infection in high-risk individuals and inhibits replication in vitro.Mucosal immunity and viral infections.Natural killer cells and the syndrome of chronic natural killer cell lymphocytosis.Glucocorticoid dysregulation of natural killer cell function through epigenetic modificationControl or persistence of hepatitis B virus: the critical role of initial host-virus interactions.Lambda interferon (IFN-lambda), a type III IFN, is induced by viruses and IFNs and displays potent antiviral activity against select virus infections in vivo.Activation of human macrophages by bacterial components relieves the restriction on replication of an interferon-inducing parainfluenza virus 5 (PIV5) P/V mutantMouse ENU Mutagenesis to Understand Immunity to Infection: Methods, Selected Examples, and Perspectives.NK T cells contribute to expansion of CD8(+) T cells and amplification of antiviral immune responses to respiratory syncytial virus.Cerebral expression of interleukin-12 induces neurological disease via differential pathways and recruits antigen-specific T cells in virus-infected mice.Social disruption induced priming of CNS inflammatory response to Theiler's virus is dependent upon stress induced IL-6 releaseRole of interleukin-12 and stat-4 in the regulation of airway inflammation and hyperreactivity in respiratory syncytial virus infection.Lymphotoxin and LIGHT signaling pathways and target genes.Sequential polymicrobial infections lead to CNS inflammatory disease: possible involvement of bystander activation in heterologous immunity.Innate immune control of HIV.Inflammatory IL-15 is required for optimal memory T cell responses.Race- and gender-related variation in natural killer p46 expression associated with differential anti-hepatitis C virus immunity
P2860
Q24317152-C2FD4A90-6BF4-4CA5-B1C8-CCC2A059D1F0Q24814677-22AA8EDC-B32D-4C97-B475-41E09920F153Q27002588-1F7FB755-B2AA-4127-B08E-90CE4E00264CQ27005694-D7464797-B19D-432A-B519-2C8280A6D99EQ27023801-EA522340-606B-47B5-84D1-A2839946A36BQ27469650-F8A44D38-7F96-4D39-86DD-11B31DE7E933Q27470232-98527095-18FE-444D-A934-7FFAD1EAD8FCQ27472373-C50EC30D-9BD3-4D3E-B667-B00CD3EABD16Q28391714-E24F30A7-51AC-4AFB-B688-4349CBF55D40Q29248781-C85374F3-0050-4B7C-AF73-46B690AD6318Q30306117-FFA1AD34-1276-4A29-8C4A-7E02A4D1EDE2Q30308011-6DFB4709-92FF-4039-986D-4BE5BF173037Q30360065-9EC8FDFF-2C93-444D-837F-17FC1BB02042Q33389846-1ADBFA30-8A0B-44DC-9961-E0492C25DF41Q33707533-BA505997-0F98-4129-8B00-AE9FA3C0AEE9Q33741498-241D987F-E01E-4415-9CED-DB8219FA4E01Q33803192-040CDC8B-A864-4C18-B72F-809CB9992EFFQ33835204-0AEAF287-E428-48B2-BDF3-B07DD991391BQ33874809-A9C51866-13FB-4B3E-9F9E-80F448178871Q34019902-5D1FB6EF-EC35-4ED8-8EF7-4963498EEB69Q34022257-6F84FF57-D8FC-46DA-B5B5-3F08078DB87CQ34109760-C447AC6F-4558-4D15-9987-CBA6E801C070Q34152457-12EAEE89-5DA4-4F8A-BDBF-2978E100048FQ34259130-00EA250F-949D-47BD-B53A-945D8B720319Q34259769-F160FFC0-E3DC-4DC2-9F99-332DBEC53E6FQ34265200-416C90BD-9B19-4EAD-B95B-DDDAB970817CQ34338570-D2CF9102-5992-4D42-A0B3-6DD653F17427Q34546460-D4BB96A3-B01F-4D7F-8CE2-5A9B3901D57CQ34647423-16A05C4A-7E09-449B-A684-FB34BFD56FB1Q34669410-718FEB4C-4177-4EB8-8F8A-B0089DEF05B0Q34774733-93832082-B1BE-427A-B6D5-43EC782337EDQ34999264-F22281C1-3FE7-489B-8DD3-DC5B6D3F9E2FQ35103078-CD804A98-4A49-4C97-86EE-D6A6F0C2BF72Q35489039-4EBE9A12-7EE6-4F82-9774-1A9FB38B74DBQ35746966-40293D0E-DF42-486E-B98D-63AEB137DE78Q35951798-F2EA6145-11BD-4F13-9130-5C53C4D35DADQ36004599-6DAD3702-29D3-45AF-AC07-CC741A77D4BDQ36065864-1459B8BB-10DB-4513-9839-B1236B2F9423Q36106046-89D7FC77-6DE8-4F38-9DA8-C50B14AAEBEAQ36279154-51296138-0643-4471-A4D9-7411432ECE43
P2860
Initial and innate responses to viral infections--pattern setting in immunity or disease.
description
1999 nî lūn-bûn
@nan
1999 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
name
Initial and innate responses to viral infections--pattern setting in immunity or disease.
@ast
Initial and innate responses to viral infections--pattern setting in immunity or disease.
@en
type
label
Initial and innate responses to viral infections--pattern setting in immunity or disease.
@ast
Initial and innate responses to viral infections--pattern setting in immunity or disease.
@en
prefLabel
Initial and innate responses to viral infections--pattern setting in immunity or disease.
@ast
Initial and innate responses to viral infections--pattern setting in immunity or disease.
@en
P1476
Initial and innate responses to viral infections--pattern setting in immunity or disease.
@en
P2093
P304
P356
10.1016/S1369-5274(99)80066-6
P577
1999-08-01T00:00:00Z